Related Experiment Video
Updated: Aug 4, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein
Ailing Ji1, Andrea C Trumbauer1, Victoria P Noffsinger1
1Barnstable Brown Diabetes Center, University of Kentucky, Lexington, KY, USA; Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
Insights
Serum amyloid A (SAA) augments the pro-atherosclerotic effects of cholesteryl ester transfer protein (CETP). Deficiency of SAA prevents CETP-driven atherosclerosis, suggesting CETP inhibition benefits patients with high SAA levels.
Area of Science:
- Cardiovascular Science
- Immunology
- Lipid Metabolism
Background:
- Serum amyloid A (SAA) is a pro-atherogenic protein implicated in cardiovascular disease (CVD).
- High-density lipoprotein (HDL) normally masks SAA's pro-inflammatory effects.
- Cholesteryl ester transfer protein (CETP) remodeling of HDL liberates SAA, restoring its pro-atherogenic activity.
Purpose of the Study:
- To investigate if SAA deficiency suppresses the pro-atherogenic effects of CETP.
- To determine the role of SAA in CETP-mediated atherosclerosis.
Main Methods:
- Utilized apolipoprotein E knockout (ApoE-/-) mice and ApoE-/- mice lacking SAA isoforms (SAA-TKO).
- Adeno-associated virus-mediated expression of CETP was employed in these mouse models.
- Quantified atherosclerotic lesion area in the aortic arch and analyzed plasma lipids and inflammatory markers.
Main Results:
- CETP expression significantly increased atherosclerosis in ApoE-/- mice but not in ApoE-/- SAA-TKO mice.
- No significant effects of CETP or SAA genotype on plasma lipids or inflammatory markers were observed.
- Increased atherosclerosis in CETP-expressing ApoE-/- mice correlated with elevated SAA in aortic root sections.
Conclusions:
- SAA significantly augments the atherogenic effects of CETP.
- Targeting CETP may offer therapeutic benefits for individuals with elevated SAA levels.
- SAA plays a critical role in mediating CETP-induced atherosclerosis.
Abstract:
Serum amyloid A (SAA) is predictive of CVD in humans and causes atherosclerosis in mice. SAA has many proatherogenic effects in vitro. However, HDL, the major carrier of SAA in the circulation, masks these effects. The remodeling of HDL by cholesteryl ester transfer protein (CETP) liberates SAA restoring its proinflammatory activity. Here, we investigated whether deficiency of SAA suppresses the previously described proatherogenic effect of CETP. ApoE-/- mice and apoE-/- mice deficient in the three acute-phase isoforms of SAA (SAA1.1, SAA2.1, and SAA3; "apoE-/- SAA-TKO") with and without adeno-associated virus-mediated expression of CETP were studied. There was no effect of CETP expression or SAA genotype on plasma lipids or inflammatory markers. Atherosclerotic lesion area in the aortic arch of apoE-/- mice was 5.9 ± 1.2%; CETP expression significantly increased atherosclerosis in apoE-/- mice (13.1 ± 2.2%). However, atherosclerotic lesion area in the aortic arch of apoE-/- SAA-TKO mice (5.1 ± 1.1%) was not significantly increased by CETP expression (6.2 ± 0.9%). The increased atherosclerosis in apoE-/- mice expressing CETP was associated with markedly increased SAA immunostaining in aortic root sections. Thus, SAA augments the atherogenic effects of CETP, which suggests that inhibiting CETP may be of particular benefit in patients with high SAA.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholinesterases: Distribution and Function
Inflammation
Atherosclerosis III: Management

